Overview
Axon Signal Labs creates AI-powered blood-based biomarker panels for early detection of traumatic brain injury and neurodegenerative disease in point-of-care settings.
More in Neurodiagnostics
Latest industry news
Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena
2026-10-31 · Industry
Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
2026-10-30 · Product
Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
2026-10-29 · Research
NeuroXess Raises 700 Million Yuan in Series B to Push 'Three-Comprehensive' BCI Into Clinical Trials
2026-10-28 · Funding
Company details
Category
🔬 Neurodiagnostics
Location
Boston, MA
Funding
Seed — $8M
Website
axonsignallabs.comListed
2026-09-21
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →